University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Hospital
Location:
Baltimore,
United States (USA) (US)
ROR: https://ror.org/01vft3j45
Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patients (2026)
Dubrovska R, Eckstein M, Jung R, Kalogirou C, Kneitz B, Spahn M, Kruithof-de Julio M, et al.
Journal article
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model. (2026)
Lachowiez CA, Zeidner JF, Othman J, Kaempf A, Yun S, Heiblig M, Heuser M, et al.
Journal article